Company Profile
ArcticZymes Technologies ASA, a life sciences company develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp alkaline phosphatase.
Its portfolio also includes cod UNG for use in viral and molecular diagnostic assays for the removal of contaminating dU-DNA, salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and reagents, and double-strand specific DNases and derived kits for the removal of double stranded DNA
DNA/RNA polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology. Its portfolio also includes proteinase for microbiological diagnostics and liquid biopsies, and ligases for joining nucleic acids. The company serves the molecular tools market, and biomanufacturing markets.
It operates in Norway, Germany, Lithuania, France, Italy, the United Kingdom, rest of Europe, the United States, and globally. Founded in 1990 and headquartered in Tromsø, Norway, ArcticZymes Technologies was formerly known as Biotec Pharmacon ASA before rebranding in June 2020.